Search - tctmd.com

Displaying 1 - 20 of 35

Sort: Relevancy | Date

CV Health Starts to Decline Around Age 10

News Daily News

CV Health Starts to Decline Around Age 10

December 23, 2024

PREDIMED Analysis May Rekindle Hope for Wine’s Heart Benefits

News Daily News

PREDIMED Analysis May Rekindle Hope for Wine’s Heart Benefits

Michael O'Riordan

December 18, 2024

Obesity Trends May Be Going in the Right Direction for the First Time in a Decade

News Daily News

Obesity Trends May Be Going in the Right Direction for the First Time in a Decade

December 18, 2024

Teens Who Smoke Face Risk of Cardiac Damage by Their Mid-20s

News Daily News

Teens Who Smoke Face Risk of Cardiac Damage by Their Mid-20s

December 12, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

Rural Counties Bore Brunt of Worsening CV Mortality During Pandemic

News Daily News

Rural Counties Bore Brunt of Worsening CV Mortality During Pandemic

Yael L. Maxwell

November 15, 2024

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

News Daily News

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

Michael O'Riordan

November 13, 2024

Private Equity Firms Own Half of Cardiology Practices: MedAxiom Survey

News Daily News

Private Equity Firms Own Half of Cardiology Practices: MedAxiom Survey

November 12, 2024

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

News Conference News VIVA 2024

Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II

November 06, 2024

Michelle Tarver Named New FDA Director of Medical Devices

News Daily News

Michelle Tarver Named New FDA Director of Medical Devices

October 25, 2024

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

Little Pre- and Postmarket Testing for Most Recalled CV Devices

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

Stop-or-Not It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery

News Conference News ESC 2024

Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery

August 30, 2024

Good News for CV Recovery After COVID-19 Vaccine Myocarditis

News Daily News

Good News for CV Recovery After COVID-19 Vaccine Myocarditis

Yael L. Maxwell

August 29, 2024

CMS Announces Negotiated Medicare Prices for First 10 Drugs

News Daily News

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Yael L. Maxwell

August 16, 2024

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

Survival After Bystander CPR in OHCA Varies by Race/Ethnicity, Sex

News Daily News

Survival After Bystander CPR in OHCA Varies by Race/Ethnicity, Sex

August 12, 2024

FDA to Add New Diversity Requirements for Certain Clinical Studies

News Daily News

FDA to Add New Diversity Requirements for Certain Clinical Studies

July 15, 2024

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

News Daily News

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Yael L. Maxwell

July 10, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.